Russell Investments Group
EWTX icon

Russell Investments Group’s Edgewise Therapeutics EWTX Stock Holding History

Russell Investments Group’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.16M Buy
77,733
+71,159
+1,082% +$2.45M ﹤0.01% 1814
2026
Q1 		$207K Buy
6,574
+80
+1% +$2.31K ﹤0.01% 2840
2025
Q4 		$161K Sell
6,494
-696
-10% -$14K ﹤0.01% 2910
2025
Q3 		$117K Buy
7,190
+7,166
+29,858% +$102K ﹤0.01% 2981
2025
Q2 		$315 Buy
24
+5
+26% +$72 ﹤0.01% 3776
2025
Q1 		$418 Sell
19
-33,060
-100% -$867K ﹤0.01% 3689
2024
Q4 		$883K Buy
+33,079
New +$1.05M ﹤0.01% 2063
2024
Q3 		– Sell
-3,070
Closed -$55.3K – 3721
2024
Q2 		$55.3K Buy
+3,070
New +$53.5K ﹤0.01% 2740

Other funds holding EWTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
QPW
Quantum Private Wealth Tampa, Florida $390M AUM 58.18% 1-Year Est. Return

Russell Investments Group's EWTX Position: Q2 2026 in Review

Russell Investments Group increased its Edgewise Therapeutics (EWTX) stake by 1,082% in Q2 2026, buying an estimated $2.45M and bringing the position to 77,733 shares worth $3.16M. The position accounts for ﹤0.01% of the portfolio, ranked #1814.

Russell Investments Group first reported a position in EWTX in Q2 2024 and has held it in 8 quarters since. 73 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • Russell Investments Group held 77,733 shares of Edgewise Therapeutics worth $3.16M as of Q2 2026.
  • Russell Investments Group bought 71,159 Edgewise Therapeutics shares in Q2 2026, an estimated $2.45M.
  • Edgewise Therapeutics made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #1814 holding.
  • Russell Investments Group first reported a position in Edgewise Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • 73 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.